Probiomics to acquire 100% stake in Hunter Immunology - MarketLine Financial Deals

Probiomics to acquire 100% stake in Hunter Immunology

Probiomics to acquire 100% stake in Hunter Immunology - MarketLine Financial Deals
Probiomics to acquire 100% stake in Hunter Immunology
Published Oct 10, 2011
2 pages — Published Oct 10, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Probiomics, Ltd., a biotechnology company, has entered into a memorandum of understanding to acquire all of the shares in Hunter Immunology Limited.

  
Source:
Document ID
MA82999_111013
Country
Ticker
PCC=AU
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Probiomics to acquire 100% stake in Hunter Immunology" Oct 10, 2011. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Probiomics-to-acquire-100-stake-in-Hunter-Immunology-2052-70840>
  
APA:
MarketLine Financial Deals. (2011). Probiomics to acquire 100% stake in Hunter Immunology Oct 10, 2011. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Probiomics-to-acquire-100-stake-in-Hunter-Immunology-2052-70840>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.